OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 07/17/2025 at 08:30, 8 months 6 days ago

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025

Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
PRESS RELEASE

published on 07/17/2025 at 08:30, 8 months 6 days ago

Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025
Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025

Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
BRIEF

published on 07/15/2025 at 18:05, 8 months 8 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF

published on 07/15/2025 at 18:05, 8 months 8 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE

published on 07/15/2025 at 18:00, 8 months 8 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation

Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/15/2025 at 18:00, 8 months 8 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek

Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
BRIEF

published on 07/14/2025 at 18:05, 8 months 9 days ago

Oxurion Announces Transparency Notifications from Atlas

Biopharmaceutical Shareholder Notification Atlas Special Opportunities Oxurion NV Transparency Legislation
BRIEF

published on 07/14/2025 at 18:05, 8 months 9 days ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence
PRESS RELEASE

published on 07/14/2025 at 18:00, 8 months 9 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation

Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/14/2025 at 18:00, 8 months 9 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV heeft transparantiekennisgevingen ontvangen volgens de Belgische wetgeving betreffende belangrijke deelnemingen. Atlas Special Opportunities II LLC heeft aanzienlijke aandelen in Oxurion verworven en verkocht. Raadpleeg www.oxurion.com voor meer informatie

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Belgische Wetgeving Atlas Special Opportunities II LLC

Published on 03/24/2026 at 07:00, 47 minutes ago

Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 47 minutes ago

Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 00:55, 6 hours 52 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 9 hours 7 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 9 hours 17 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp

View all ACCESSWIRE

Published on 03/24/2026 at 07:30, 17 minutes ago

Drägerwerk AG & Co. KGaA: Dräger with good order development, record net sales and significant increase in net profit in fiscal year 2025 – third dividend increase in a row
Published on 03/24/2026 at 07:23, 23 minutes ago

INDUS confirms a solid financial year 2025 – Proposed dividend of EUR 1.30 exceeds previous year
Published on 03/24/2026 at 07:00, 46 minutes ago

After strong fourth quarter, INFICON closes 2025 at record sales level
Published on 03/24/2026 at 07:00, 46 minutes ago

Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Published on 03/24/2026 at 07:00, 46 minutes ago

MCH Group Reports Profitability Improvement in 2025

View all EQS

Published on 03/24/2026 at 07:45, 2 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 2 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 17 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 17 minutes ago

Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 12 hours 39 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026

View all LES ECHOS COMFI WIRE

News